These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 27292200)

  • 1. Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy.
    Besler C; Urban D; Watzka S; Lang D; Rommel KP; Kandolf R; Klingel K; Thiele H; Linke A; Schuler G; Adams V; Lurz P
    Eur J Heart Fail; 2016 Dec; 18(12):1442-1451. PubMed ID: 27292200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential role of plasma miR-155 and miR-206 as circulatory biomarkers in inflammatory cardiomyopathy.
    Obradovic D; Rommel KP; Blazek S; Klingel K; Gutberlet M; Lücke C; Büttner P; Thiele H; Adams V; Lurz P; Emrich F; Besler C
    ESC Heart Fail; 2021 Jun; 8(3):1850-1860. PubMed ID: 33830643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and Cardiac Galectin-3 in Patients With Heart Failure Reflects Both Inflammation and Fibrosis: Implications for Its Use as a Biomarker.
    Besler C; Lang D; Urban D; Rommel KP; von Roeder M; Fengler K; Blazek S; Kandolf R; Klingel K; Thiele H; Linke A; Schuler G; Adams V; Lurz P
    Circ Heart Fail; 2017 Mar; 10(3):. PubMed ID: 28288987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of enteroviral RNA in endomyocardial biopsies in inflammatory cardiomyopathy and idiopathic dilated cardiomyopathy].
    Pauschinger M; Kühl U; Dörner A; Schieferecke K; Petschauer S; Rauch U; Schwimmbeck PL; Kandolf R; Schultheiss HP
    Z Kardiol; 1998 Jun; 87(6):443-52. PubMed ID: 9691414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cellular microRNA, let-7i, is a novel biomarker for clinical outcome in patients with dilated cardiomyopathy.
    Satoh M; Minami Y; Takahashi Y; Tabuchi T; Nakamura M
    J Card Fail; 2011 Nov; 17(11):923-9. PubMed ID: 22041329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relations between circulating and myocardial fibrosis-linked microRNAs with left ventricular reverse remodeling in dilated cardiomyopathy.
    Dziewięcka E; Totoń-Żurańska J; Wołkow P; Kołton-Wróż M; Pitera E; Wiśniowska-Śmiałek S; Khachatryan L; Karabinowska A; Szymonowicz M; Podolec P; Rubiś P
    Adv Clin Exp Med; 2020 Mar; 29(3):285-293. PubMed ID: 32207584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between myocardial fibrosis and myocardial microRNAs in dilated cardiomyopathy: A link between mir-133a and cardiovascular events.
    Rubiś P; Totoń-Żurańska J; Wiśniowska-Śmiałek S; Dziewięcka E; Kołton-Wróż M; Wołkow P; Pitera E; Rudnicka-Sosin L; Garlitski AC; Gackowski A; Podolec P
    J Cell Mol Med; 2018 Apr; 22(4):2514-2517. PubMed ID: 29377565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Right ventricular morphology and function is not related with microRNAs and fibrosis markers in dilated cardiomyopathy.
    Rubiś P; Totoń-Żurańska J; Wiśniowska-Śmiałek S; Kołton-Wróż M; Wołkow P; Wypasek E; Rudnicka-Sosin L; Pawlak A; Kozanecki K; Tomkiewicz-Pająk L; Podolec P
    Cardiol J; 2018; 25(6):722-731. PubMed ID: 28840590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations of the changes in bioptic findings with echocardiographic, clinical and laboratory parameters in patients with inflammatory cardiomyopathy.
    Krejci J; Hude P; Poloczkova H; Zampachova V; Stepanova R; Freiberger T; Nemcova E; Spinarova L
    Heart Vessels; 2016 Mar; 31(3):416-26. PubMed ID: 25539624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multislice spiral computed tomography of the heart in dilated cardiomyopathy: possibilities in the verification of myocarditis (in comparison with myocardial biopsy) and in the evaluation of prognosis].
    Alieva IN; Blagova OV; Gagarina NV; Nedostup AV; Kogan EA; Sedov VP; Kadochnikova VV; Donnikov AE; Zaidenov VA; Kupriyanova AG; Ternovoy SK
    Ter Arkh; 2017; 89(12):15-27. PubMed ID: 29411756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of miR-208b improves cardiac function in titin-based dilated cardiomyopathy.
    Zhou Q; Schötterl S; Backes D; Brunner E; Hahn JK; Ionesi E; Aidery P; Sticht C; Labeit S; Kandolf R; Gawaz M; Gramlich M
    Int J Cardiol; 2017 Mar; 230():634-641. PubMed ID: 28065693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM.
    Li M; Chen X; Chen L; Chen K; Zhou J; Song J
    J Transl Med; 2018 Jun; 16(1):161. PubMed ID: 29885652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of functional T-cell markers and T-cell receptor Vbeta repertoire in endomyocardial biopsies from patients presenting with acute myocarditis and dilated cardiomyopathy.
    Noutsias M; Rohde M; Göldner K; Block A; Blunert K; Hemaidan L; Hummel M; Blohm JH; Lassner D; Kühl U; Schultheiss HP; Volk HD; Kotsch K
    Eur J Heart Fail; 2011 Jun; 13(6):611-8. PubMed ID: 21422001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical, laboratory and instrumental criteria for myocarditis, established in comparison with myocardial biopsy: A non-invasive diagnostic algorithm].
    Blagova OV; Osipova YV; Nedostup AV; Kogan EA; Sulimov VA
    Ter Arkh; 2017; 89(9):30-40. PubMed ID: 29039828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the inflammatory process by endomyocardial biopsy in patients with dilated cardiomyopathy based on pathological and immunohistochemical methods.
    Prochorec-Sobieszek M; Bilińska ZT; Grzybowski J; Mazurkiewicz L; Skwarek M; Walczak E; Michalak E; Cedro K; Chmielak Z; Debski A; Demkow M; Witkowski A; Wagner T; Ruzyłło W
    Kardiol Pol; 2006 May; 64(5):479-87; discussion 488. PubMed ID: 16752331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
    Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
    Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Endomyocardial Biopsy Macrophage-Related Markers in Intractable Myocardial Diseases.
    Hayashi Y; Hanawa H; Jiao S; Hasegawa G; Ohno Y; Yoshida K; Suzuki T; Kashimura T; Obata H; Tanaka K; Watanabe T; Minamino T
    Inflammation; 2015 Dec; 38(6):2288-99. PubMed ID: 26205770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble ST2 Receptor: Biomarker of Left Ventricular Impairment and Functional Status in Patients with Inflammatory Cardiomyopathy.
    Obradovic DM; Büttner P; Rommel KP; Blazek S; Loncar G; von Haehling S; von Roeder M; Lücke C; Gutberlet M; Thiele H; Lurz P; Besler C
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
    Amorim S; Rodrigues J; Campelo M; Moura B; Martins E; Macedo F; Silva-Cardoso J; Maciel MJ
    Int J Cardiovasc Imaging; 2017 May; 33(5):605-613. PubMed ID: 28013418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the human myocardial proteome in inflammatory dilated cardiomyopathy by label-free quantitative shotgun proteomics of heart biopsies.
    Hammer E; Goritzka M; Ameling S; Darm K; Steil L; Klingel K; Trimpert C; Herda LR; Dörr M; Kroemer HK; Kandolf R; Staudt A; Felix SB; Völker U
    J Proteome Res; 2011 May; 10(5):2161-71. PubMed ID: 21417265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.